Company intelligence / Profile preview

Guiheen & Associates

Ownership: Private
Development stage: Commercial

Overview

Guiheen & Associates was a consulting group specializing in commercialization strategies for biopharmaceuticals, pharmaceuticals, and medical devices. The firm leveraged the extensive industry experience of its principal to advise companies on market entry and growth within healthcare sectors. There is no evidence the company developed its own therapeutics or technologies.

Industry: Consulting

Drug pipeline

3 assets

BIVIGAM

Commercial

Indications: Primary Immunodeficiency Disease

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Guiheen & Associates.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guiheen & Associates.

Explore the full profile